Acrescent

memantine hydrochloride; donepezil hydrochloride · H. Lundbeck A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Acrescent, covering 2013-03-11 to 2013-03-11. Get the full timeline:

Most recent: EMA Refused: Acrescent (memantine hydrochloride;donepezil hydrochloride) — H. Lundbeck A/S